Newest findings on the oldest oncogene; how activated src does it

Margaret C Frame1

  • 1Cancer Research UK Beatson Laboratories, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK. m.frame@beatson.gla.ac.uk

Insights

Oncogenic Src kinases drive cancer by altering cell structure and signaling pathways. New research identifies key Src substrates involved in cell migration, proliferation, and survival during transformation.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Biochemistry

Background:

  • Oncogenic non-receptor tyrosine kinase Src plays a critical role in cancer progression.
  • Src influences fundamental cellular processes including migration, proliferation, and survival.
  • Src signaling impacts the actin cytoskeleton, adhesion networks, and transcription factors.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which oncogenic Src kinases mediate cellular transformation.
  • To identify novel Src substrates and signaling pathways involved in cancer cell behavior.
  • To understand Src's role in regulating cell migration, invasion, and survival.

Main Methods:

  • Analysis of Src signaling pathways, including RhoA-ROCK, STAT, and Cbl.
  • Investigation of focal adhesion kinase (FAK) downstream of v-Src.
  • Identification and characterization of novel Src substrates and their interactions.

Main Results:

  • Oncogenic Src influences the RhoA-ROCK pathway, STAT transcription factors, and Cbl ubiquitin ligase.
  • Focal adhesion kinase (FAK) is a key downstream mediator of v-Src in transformed cells.
  • Novel Src substrates such as Hakai, Fish, and connexin 43 were identified, highlighting their roles in transformation-associated events.

Conclusions:

  • Src kinases are central regulators of cell structure and signaling in cancer.
  • Identification of new Src substrates provides deeper insight into transformation mechanisms.
  • Targeting Src and its downstream effectors holds potential for cancer therapy.

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...